Zoga, E.; Wolff, R.; Ackermann, H.; Meissner, M.; Rödel, C.; Tselis, N.; Chatzikonstantinou, G.
Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers 2022, 14, 2391.
https://doi.org/10.3390/cancers14102391
AMA Style
Zoga E, Wolff R, Ackermann H, Meissner M, Rödel C, Tselis N, Chatzikonstantinou G.
Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers. 2022; 14(10):2391.
https://doi.org/10.3390/cancers14102391
Chicago/Turabian Style
Zoga, Eleni, Robert Wolff, Hanns Ackermann, Markus Meissner, Claus Rödel, Nikolaos Tselis, and Georgios Chatzikonstantinou.
2022. "Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies" Cancers 14, no. 10: 2391.
https://doi.org/10.3390/cancers14102391
APA Style
Zoga, E., Wolff, R., Ackermann, H., Meissner, M., Rödel, C., Tselis, N., & Chatzikonstantinou, G.
(2022). Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers, 14(10), 2391.
https://doi.org/10.3390/cancers14102391